αV integrins in angiogenesis and cancer
SM Weis, DA Cheresh - Cold Spring …, 2011 - perspectivesinmedicine.cshlp.org
During angiogenesis, αv integrins are overexpressed on the endothelial cell surface to
facilitate the growth and survival of newly forming vessels. Accordingly, blocking αv integrin …
facilitate the growth and survival of newly forming vessels. Accordingly, blocking αv integrin …
Combinatorial peptide libraries: mining for cell-binding peptides
BP Gray, KC Brown - Chemical reviews, 2014 - ACS Publications
The surface of a cell represents a collection of macromolecules, which provides the cell with
a unique cellular landscape specific to the type and state of the cell. Ligands that …
a unique cellular landscape specific to the type and state of the cell. Ligands that …
Bifunctional compounds as molecular degraders for integrin-facilitated targeted protein degradation
J Zheng, W He, J Li, X Feng, Y Li, B Cheng… - Journal of the …, 2022 - ACS Publications
As effective ways to regulate protein levels, targeted protein degradation technologies have
attracted great attention in recent years. Here, we established a novel integrin-facilitated …
attracted great attention in recent years. Here, we established a novel integrin-facilitated …
Peptides and peptide hormones for molecular imaging and disease diagnosis
Molecular imaging techniques are now indispensable tools in modern diagnostics, because
they are highly specific and can provide biological information at the molecular level in living …
they are highly specific and can provide biological information at the molecular level in living …
Self-Immolative Photosensitizers for Self-Reported Cancer Phototheranostics
C Wang, Y Sun, S Huang, Z Wei, J Tan… - Journal of the …, 2023 - ACS Publications
Photosensitizers to precise target and change fluorescence upon light illumination could
accurately self-report where and when the photosensitizers work, enabling us to visualize …
accurately self-report where and when the photosensitizers work, enabling us to visualize …
RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy
S Fu, X Xu, Y Ma, S Zhang, S Zhang - Journal of Drug Targeting, 2019 - Taylor & Francis
Integrin αvβ3 is restrictedly expressed on angiogenic blood vessels and tumour cells. It
plays a key role in angiogenesis for tumour growth and metastasis. RGD peptide can …
plays a key role in angiogenesis for tumour growth and metastasis. RGD peptide can …
Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications
KC Brown - Current pharmaceutical design, 2010 - ingentaconnect.com
Cancer has become the number one cause of death amongst Americans, killing
approximately 1,600 people per day. Novel methods for early detection and the …
approximately 1,600 people per day. Novel methods for early detection and the …
Near‐infrared molecular probes for in vivo imaging
X Zhang, S Bloch, W Akers… - Current protocols in …, 2012 - Wiley Online Library
Cellular and tissue imaging in the near‐infrared (NIR) wavelengths between 700 and 900
nm is advantageous for in vivo imaging because of the low absorption of biological …
nm is advantageous for in vivo imaging because of the low absorption of biological …
Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering
Z Guo, B He, H Jin, H Zhang, W Dai, L Zhang, H Zhang… - Biomaterials, 2014 - Elsevier
Receptor change induced by ligand binding is a new issue to face in the field of targeted
delivery. Receptor clustering, the main pattern of receptor changes, decreases the affinity …
delivery. Receptor clustering, the main pattern of receptor changes, decreases the affinity …
Radiometallated peptides for molecular imaging and targeted therapy
JDG Correia, A Paulo, PD Raposinho, I Santos - Dalton Transactions, 2011 - pubs.rsc.org
In developed countries, cancer is the second leading cause of death, being only surpassed
by cardiovascular diseases. To develop tumor-targeted tools to localize and treat cancer at …
by cardiovascular diseases. To develop tumor-targeted tools to localize and treat cancer at …